On September 10, 2009 KEI hosted a brownbag lunch to discuss the scope of patentable subject matter, focusing specifically on the implications for life-science patents of the Supreme Court’s forthcoming review of the Bilski Federal Circuit opinion. This is the first time since 1981 that the US Supreme Court will address the limits of patentable subject matter.
The key U.S. statue on this issue is Section 101 of the patent law:
On July 6, 2009, a report of the the U.S.-Japan Regulatory Reform and Competition Policy Initiative was presented to President Obama and Prime Minister Aso of Japan. The report provides an insight into the degree that the U.S. government tries to influence prices for medicines and medical devices in foreign markets. Here, as in other foreign markets, the U.S. government seeks to raise prices, and to give industry an even greater role in setting the prices for their products.
According to a report by Duff Wilson in the Sunday New York Times, Much of PhRMA’s $150 million in advertising will be spent pushing Senator Baucus’s version of the health “reform” legislation.
Delegates should reject the 20 April non-paper. The 1974 Brussels Convention on the Distribution of Programme-Carrying Signals Transmitted by Satellite” May Provide A Useful Model for a Signal-Based Treaty
The following is the text that was prepared in 2005 as a
possible basis for a treaty on Access to Knowledge. The text
was prepared in response to an August 2004 proposal by Argentina
and Brazil for a WIPO Development Agenda, that included in its
original proposal, a possible treaty on access to knowledge. The
process that created this specific draft text included three
elements.
To provide some context to discussions on the term of protection for copyright and related rights, the following note sumarizes on the basic provisions in various multilateral copyright and related rights treaties, on the topics of minimum terms and formalities. … Continue Reading →